COMMUNIQUÉS West-GlobeNewswire
-
23andMe Partners with HealthEx to Connect Medical Records with Your DNA for the Future of Personalized Medicine
20/05/2026 -
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
20/05/2026 -
Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk
20/05/2026 -
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
20/05/2026 -
Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA
20/05/2026 -
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
20/05/2026 -
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
20/05/2026 -
Glass House Brands to Host Investor Sesh V on Thursday, June 18, 2026
20/05/2026 -
Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
20/05/2026 -
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
20/05/2026 -
Sustainability Leader Ashley McKeon Selected as Soil Health Institute’s President and CEO
20/05/2026 -
Vistin Pharma ASA: Minutes from the annual general meeting 2026
20/05/2026 -
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026 -
Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
20/05/2026 -
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
20/05/2026 -
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity
20/05/2026 -
Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade
20/05/2026 -
BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent
20/05/2026 -
Alzheimer’s Research Sites Honor National Clinical Trials Day
20/05/2026
Pages